what is the difference between glp 1 2 and 3 GLP-1 agonists approved for clinical use. GLP-1 agonists are available GLP-1 vs GLP-2 vs GLP-3:

Thank you so much for your support!

The first tesamorelin human trials (Phase 1) began in the early 2000s, with Phase 3 trial dates spanning 2005-2008 (Study LIPO-010 Phase 3 completed 2008), leading to the November 2010 approval

Tell your doctor if you have any new or worsening symptoms including: Shortness of breath Sudden weight gain Swelling of your ankles or feet Tell your doctor about all the medications you take, including OTC medicines, vitamins, and supplements, and herbal supplements

2023 Dec;12(4):45373

Accelerated shortening means accelerated aging and sickness and reduced cellular and tissue function

Perhaps this reveals that we have not yet fully accepted obesity for what it truly is: not a condition to be temporarily corrected, but a chronic disease to be managed over time